BMO Capital Maintains Outperform on Salesforce, Lowers Price Target to $335

-1.10% Pre

Salesforce.com, inc.

CRM

0.00

BMO Capital analyst Keith Bachman maintains Salesforce (NYSE: CRM) with a Outperform and lowers the price target from $350 to $335.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Stock Ratings | Potential Upside of 284.62%! Leerink Partners initiated coverage of Ovid Therapeutics (OVID) with an "Outperform" rating and a $5 price target.

Saudi Crown Prince's US Visit Confirms $1 Trillion Investment Boost

Option Signals | AI Frenzy Expands! Option Volumes Surge for Microsoft, Nvidia; Nvidia Options Signal US$320 Billion Shakeup

Workday Bets Big On 'Actionable AI' With Pipedream Deal

Everyone's Buzzing About Google's Gemini 3! What Are the Related U.S. Stock Investment Opportunities?

Elon Musk Says Starship Can Deliver 300 GW Solar AI Satellites Per Year, But There's One Major 'Piece Of The Puzzle' That Stands In Its Way

Salesforce (CRM): Examining Current Valuation After Recent Share Price Dip

Salesforce Cuts Off Gainsight App Access After Detecting Data Exposure Risk—Mandiant Launches Investigation